Submit an NDA for trofinetide for the treatment of Rett syndrome
Delivered after the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 28 Feb 2022
- Due
- 30 Jun 2022
- Delivered
- July 2022
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“plan to submit an NDA to the FDA around mid-year 2022”
What we found
Evidence strength A What the grades mean
The company committed to submitting the NDA by mid-year 2022 (June 30), but filings confirm the submission occurred in July 2022.
-
A Acadia Pharmaceuticals Inc. 10-Q filed 2022-08-09
“we submitted to the FDA an NDA for trofinetide for the treatment of Rett syndrome in July 2022.” ✓ confirmed on the page
Market reaction: the shares moved -7.0% against the S&P 500 over the three sessions around the disclosure (8 Aug 2022 to 11 Aug 2022). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory submission
- Indicative materiality
- High rules
- Action
- Submit
- Deliverable
- NDA for trofinetide
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Acadia Pharmaceuticals Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2022-ACAD-002575 · Corrections policy